EBOS Group Limited

ASX:EBO

EBOS Group Limited

ASX:EBO
TradeAdd trade order Follow Unfollow Set Price Alert
$33.14 (-0.2%)
Last close price
--
Rank
0
Held by
9
Followers
TradeAdd trade order Follow Unfollow Set Price Alert
Reports (2) My Report Forum Investors
Top member reports
Consensus
No meetings
Consensus community valuation
The consensus valuation is for members only and has been removed from this chart. Click for membership options.
Become a member
Contributing Members
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
Become a member
#Industry/competitors
stale
BoredSaint
Added 2 years ago
View author's company report

Announcement today from Sigma Healthcare (ASX:SIG) that they have been awarded the Chemist Warehouse Supply Contract starting July 1 2024 and running for 4 years.

This contract was previously supplied by EBOS group and generated around $1.9b of revenue per annum (Unsure if this figure is NZD or AUD). Total revenue that EBOS generated in FY22 was around $10.7b.

EBOS have stated that they still have multiple other growth opportunities including in Institutional Health Care distribution as well as Animal Care. But obviously the loss of this contact is going to be a hit to both the top and bottom line.

Shares are taking a hit today as a result of this announcement. Previously I thought that the price was a bit too high given the competitive nature of the pharmacy distribution industry and the announcement today clearly shows the risks involved with such a business. With the price coming down, it makes things a little more interesting although I will probably wait for some more clarity as to how this loss of contract is going to affect the business as a whole.

Sigma announcement here

EBOS announcement here

Disc: Not held.


Read More
Valuation of $30.00
stale
BoredSaint
Added 2 years ago

Original Valuation - 07/09/2022

Interesting company in the healthcare distribution industry. Have only had a brief look so will just do a simple valuation.

EBOS made a few acquisitions this year so the numbers are a bit messy.

Underlying NPAT was around $228.2m

Applying a 25x PE to underlying earnings gives a valuation around $30

a 20x PE would give a valuation around $24.

Will continue to watch for now unless the share price comes down to below $30.

Disc: Not held

Read More